PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Dipartimento di Scienze della Salute, Università \'Magna Græcia\' di Catanzaro, Campus \'S. Venuta\', Catanzaro, Italy; Net4Science Academic Spin-Off, Università \'Magna Græcia\' di Catanzaro, Campus \'S. Venuta\', Catanzaro, Italy.\', \'Department of Experimental Medicine, University of Rome Tor Vergata, Rome, Italy.\', \'Dipartimento di Scienze della Salute, Università \'Magna Græcia\' di Catanzaro, Campus \'S. Venuta\', Catanzaro, Italy.\', \'The Fred Wyszkowski Cancer Research Lab, Faculty of Biology, Technion, Israel Institute of Technology, Haifa, Israel.\', \'Department of Experimental Medicine, University of Rome Tor Vergata, Rome, Italy. Electronic address: ceccherini@med.uniroma2.it.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • S1368-7646(20)30050-910.1016/j.drup.2020.100721
?:hasPublicationType
?:journal
  • Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy
is ?:pmid of
?:pmid
?:pmid
  • 33132205
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
is ?:relation_isRelatedTo_publication of
?:title
  • Current status of antivirals and druggable targets of SARS CoV-2 and other human pathogenic coronaviruses.
?:type
?:year
  • 2020

Metadata

Anon_0  
expand all